The potential of bovine vaginal smear for biomarker development to trace the misuse of anabolic agents.
Riedmaier
I
I
Physiology Weihenstephan, Technische Universität Muenchen, Weihenstephaner Berg, Freising, Germany. irmgard.riedmaier@wzw.tum.de
Reiter
M
M
Tichopad
A
A
Pfaffl
M W
MW
Meyer
H H D
HH
D045930:Anabolic Agents / Q000032:analysis / Q000302:isolation & purification; D000818:Animals; D054316:Biomarkers, Pharmacological / Q000032:analysis*; D002417:Cattle / Q000254:growth & development / Q000502:physiology; D004338:Drug Combinations; D004343:Drug Implants; D004958:Estradiol / Q000008:administration & dosage; D005260:Female; D008461:Meat Products / Q000032:analysis / Q000592:standards; D011374:Progesterone / Q000097:blood; D020871:RNA Stability / Q000502:physiology; D020133:Reverse Transcriptase Polymerase Chain Reaction / Q000379:methods / Q000592:standards; D015813:Substance Abuse Detection / Q000379:methods* / Q000662:veterinary; D014204:Trenbolone Acetate / Q000008:administration & dosage / Q000031:analogs & derivatives; D014626:Vaginal Smears / Q000706:statistics & numerical data / Q000662:veterinary*
D045930:Anabolic Agents; D054316:Biomarkers, Pharmacological; D004338:Drug Combinations; D004343:Drug Implants; C021828:Revalor; D011374:Progesterone; D004958:Estradiol; D014204:Trenbolone Acetate